Skyepharma has made an application to the UK Listing Authority (UKLA) and the London Stock Exchange for the listing of 1,100,000 ordinary shares of each to be admitted to the UKLA Official List and to trade on the London Stock Exchange.
According to the company’s Monday press release those shares are being reserved under a block listing and will be issued to the Company’s Employee Benefit Trusts to enable those trusts to be in a position to meet demand from the exercise of share options pursuant to the Company’s 2012 Long Term Incentive Plan and its 2014 International Share Incentive Plan.
It is expected that the admission of the Ordinary Shares will become effective today, March 22, 2016.
These Ordinary Shares will rank pari passu with existing Ordinary Shares of the Company.